Elevated homocystein and gastrointestinal disease;Gastrointestinal sykdom ved forhøyet plasma-homocysteinnivå

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 24, 1999, Pages 3577-3579

  Coll, Peter ^a   Guttormsen, Anne Berit ^a   Berstad, Arnold ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE;

ARTICLE; BLOOD; CELIAC DISEASE; CROHN DISEASE; GASTROINTESTINAL DISEASE; GENETICS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MUTATION; PATHOLOGY; ULCERATIVE COLITIS;

BIOLOGICAL MARKERS; CELIAC DISEASE; COLITIS, ULCERATIVE; CROHN DISEASE; GASTROINTESTINAL DISEASES; HETEROZYGOTE; HOMOCYSTEINE; HOMOZYGOTE; HUMANS; MUTATION;

EID: 0033543907     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ulvik RJ, Ueland PM, Refsum H. Rutinemessig bestemmelse av homocystein i plasma. Tidsskr Nor Lægeforen 1992; 112: 2977-80.
2. Kang SS, Zhou J, Wong PWK, Kowalisyn J, Strokosh G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988; 43: 414-21.
3. Brattström LE, Israelsson B, Jeppsson JO, Hultberg BL. Folic acid - an innocous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988; 48: 215-21.
4. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
5. Boushey CJ. Beresford SA, Omenn GS, Motulsky AG. A quantitativ assessment of plasma homocysteine as risk factor for vascular disease: probable benefits of increasing folk acid intake. JAMA 1995; 274: 1049-57.
6. Nygård O, Norderhaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-6.
7. Welch GN, Upchurch GR jr., Loscalzo J. Hyperhomoeyst(e)inemia and atherothrombosis. Ann N Y Acad Sci 1997; 811: 48-58.
8. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131-7.
9. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin. Ann Intern Med 1994; 120: 211-5.
10. 12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 1994; 39: 2159-62.
11. Selhub J, Jacques PF, Rush D, Rosenberg IH. Vitamine status and intake as primaiy determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-8.
12. Guttormsen AB, Refsum H, Nesthus I, Nygård O, Schneede J, Vollset SE et al. Determinants and vitamin responsivness of intermediate hyperhomocysteinemia (> 40 micromol/1). The Hordaland Homocysteine Study. J Clin Invest 1996; 98: 2174-83.
13. Andus T, Møllers C, Geissler A, Vogl D, Gross V, Schmitz G et al. Elevated homocystein in sera of patients with inflammatory bowel disease. Gastroenterology 1996; 110: A855.